Legal Alert - Pharmaceutical Company Seeks to Use Tribal Sovereign Immunity to Avoid Inter Partes Review
September 14, 2017
by Heidi McNeil Staudenmaier and Jenny Hua
Allergan announced on September 8, 2017, that it had transferred its patents covering the drug Restasis to the Saint Regis Mohawk Tribe and will pay the tribe $13.75 million. The tribe is also eligible to receive $15 million in annual royalties as long as the patents remain valid. In exchange, Allergan was given an exclusive license to the patents.
©2024 Snell & Wilmer L.L.P. All rights reserved. The purpose of this publication is to provide readers with information on current topics of general interest and nothing herein shall be construed to create, offer, or memorialize the existence of an attorney-client relationship. The content should not be considered legal advice or opinion, because it may not apply to the specific facts of a particular matter. As guidance in areas is constantly changing and evolving, you should consider checking for updated guidance, or consult with legal counsel, before making any decisions.
City National 2CAL
| 350 South Grand Avenue
| Suite 3100
| Los Angeles, CA 90071-3420
The material in this newsletter may not be reproduced, distributed, transmitted, cached or otherwise used, except with the written permission of Snell & Wilmer.
The material in this newsletter may not be reproduced, distributed, transmitted, cached or otherwise used, except with the written permission of Snell & Wilmer.